莱伯泰科(688056) - 2024年3月22日投资者关系活动记录表

Financial Performance - In 2023, the company's operating profit, total profit, net profit attributable to shareholders, and net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 43.50%, 43.46%, 37.05%, and 42.73% respectively compared to the previous year [2] - The decrease in operating profit is primarily due to a goodwill impairment of approximately 5 million related to the acquisition of CDS Analytical, LLC, and an increase in share-based payment expenses from 1.50 million in 2022 to 6.10 million in 2023, an increase of 459.53% [2] - After excluding the impacts of goodwill impairment and share-based payments, the net profit attributable to shareholders decreased by approximately 15.50% compared to 2022, mainly due to increased production costs and intensified market competition leading to a three percentage point decline in overall product gross margin [3] Strategic Adjustments - The company plans to implement several measures to improve profitability, including targeted sales personnel training, adjustments to sales bonuses, and strict control over financial expenditures [3] - The company aims to enhance research and development efficiency and increase the contribution of R&D to sales growth while controlling personnel increases [3] Customer Base and Market Position - The company's downstream customers primarily include government departments, research institutions, universities, third-party testing companies, and enterprise clients, with a slight increase in revenue share from enterprise clients and research institutions in recent years [3] - The ICP-MS product is evaluated based on performance indicators such as detection limits and sensitivity, with positive feedback received regarding its stability and accuracy, particularly in the semiconductor industry [4] Competitive Landscape - The domestic ICP-MS market is dominated by imported products, with the company focusing on leveraging its product performance and stability rather than engaging in price wars, especially in the semiconductor sector where price sensitivity is low [4] - The company is closely monitoring policies related to large-scale equipment updates, which are expected to provide favorable conditions for the scientific instrument industry [4]